Why does label-free lymphocyte identification matter for target validation?

It enables assessment of immunomodulatory targets without altering cellular function via fluorescent labels, preserving native phenotype for accurate hypothesis testing. This reduces false positives and mechanistic ambiguity in early discovery. The method supports confident target de-risking by linking label-free morphological and biochemical features to immune cell identity.

How does 3D refractive index tomography enable independent variable isolation in lymphocyte studies?

It isolates intrinsic biophysical properties (e.g., refractive index, density, morphology) as independent variables by eliminating exogenous labels that can confound interpretation. This allows researchers to attribute observed changes directly to biological or therapeutic perturbations. The quantitative nature of RI tomograms supports reproducible isolation of variables across experimental conditions.

What quantitative dependent variable measurements does this method enable for immune profiling?

The method enables measurement of cellular volume, surface area, sphericity, protein density, and dry mass per cell as dependent variables derived from 3D RI tomograms. These parameters provide multiparametric, label-free phenotyping of lymphocyte subtypes. Such quantitative outputs allow objective comparison of immune cell states across treatment groups or disease models.

Why are replication requirements important for cross-functional collaboration in label-free immune profiling?

Replication ensures that 3D RI tomogram quality and machine learning classification accuracy are consistent across users, sites, and timepoints, which is essential for reliable data sharing. Standardized imaging and feature extraction protocols reduce variability and enable comparability between discovery, preclinical, and translational teams. This supports aligned decision-making in immune-focused drug development programs.

What statistical analysis capabilities are required before implementing this method in immune discovery workflows?

Implementation requires capability to split feature datasets into training and test sets, train classifiers (e.g., K-nearest neighbor), and evaluate accuracy using cross-validation or holdout testing. Statistical validation of classification performance (e.g., 80% accuracy) is needed to confirm method suitability for immune subtyping. These capabilities ensure that label-free identification is robust, reproducible, and fit for purpose in R&D settings.

Identificazione dei sottotipi del linfocita usando la formazione immagine tridimensionale fase quantitativa privo di etichetta e Machine Learning

11.7K visualizzazioni

Citato da 12

08:58 min

19 novembre 2018

10.3791/58305-v

19 novembre 2018

11.7K visualizzazioni

Jonghee Yoon¹ , YoungJu Jo²^,³^,⁴^,⁷ , Young Seo Kim³^,⁴^,⁵ , Yeongjin Yu²^,³ , Jiyeon Park⁶ , Sumin Lee⁴ , Wei Sun Park²^,³ , YongKeun Park²^,³^,⁴

¹Department of Physics, University of Cambridge, ²Department of Physics, Korea Advanced Institute of Science and Technology, ³KAIST Institute for Health Science and Technology, Korea Advanced Institute of Science and Technology, ⁴Tomocube, Inc., ⁵Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology, ⁶Department of Biological Sciences, Korea Advanced Institute of Science and Technology, ⁷Department of Applied Physics, Stanford University

Descriviamo un protocollo per l'identificazione di sottotipi del linfocita usando formazione immagine fase quantitativa e un algoritmo di apprendimento automatico privo di etichetta. Misurazioni dell'indice di rifrazione 3D tomogrammi dei linfociti presentano 3D informazioni morfologiche e biochimiche per le singole celle, che viene quindi analizzati con un algoritmo di apprendimento automatico per l'identificazione di tipi delle cellule.